To schedule your appointment, sign up or speak with our weight loss specialists, call (424) 382-1074
Clinical trials of FDA-approved semaglutide and tirzepatide show average weight loss of 1521% of total body weight, far beyond what lifestyle changes alone typically achieve (individual results vary and are not guaranteed)
A 2022 study compared people in France who did and didnt take semaglutide, and found higher rates of thyroid cancer in people who used semaglutide, especially after 1 to 3 years of use
No insurance is required, and HSA/FSA accounts cover both medication and genetic testing
GLP-1 medications are the hottest way to lose weight, but are all versions of the drug being marketed to you safe
Helps patients begin GLP-1 therapy with a lower introductory dose